Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Current methods of pharmacologic stress testing and the potential advantages of new agents.

Botvinick EH.

J Nucl Med Technol. 2009 Mar;37(1):14-25. doi: 10.2967/jnmt.108.057802. Review.

2.

Pharmacological stress testing.

Travain MI, Wexler JP.

Semin Nucl Med. 1999 Oct;29(4):298-318. Review.

PMID:
10534233
3.

Advances in pharmacologic stress agents: focus on regadenoson.

Johnson SG, Peters S.

J Nucl Med Technol. 2010 Sep;38(3):163-71. doi: 10.2967/jnmt.109.065581. Review.

4.

Advances in pharmacologic agents in imaging: new A2A receptor agonists.

Cerqueira MD.

Curr Cardiol Rep. 2006 Mar;8(2):119-22. Review.

PMID:
16524538
5.

Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications.

Palani G, Ananthasubramaniam K.

Cardiol Rev. 2013 Jan-Feb;21(1):42-8. doi: 10.1097/CRD.0b013e3182613db6. Review.

PMID:
22643345
6.

Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.

Mekkaoui C, Jadbabaie F, Dione DP, Meoli DF, Purushothaman K, Belardinelli L, Sinusas AJ.

JACC Cardiovasc Imaging. 2009 Oct;2(10):1198-208. doi: 10.1016/j.jcmg.2009.06.013.

7.

Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.

Hendel RC, Bateman TM, Cerqueira MD, Iskandrian AE, Leppo JA, Blackburn B, Mahmarian JJ.

J Am Coll Cardiol. 2005 Dec 6;46(11):2069-75.

8.

Regadenoson: a new myocardial stress agent.

Al Jaroudi W, Iskandrian AE.

J Am Coll Cardiol. 2009 Sep 22;54(13):1123-30. doi: 10.1016/j.jacc.2009.04.089. Review. Erratum in: J Am Coll Cardiol. 2009 Oct 20;54(17):1635.

9.

Regadenoson in the detection of coronary artery disease.

Buhr C, Gössl M, Erbel R, Eggebrecht H.

Vasc Health Risk Manag. 2008;4(2):337-40. Review.

10.

Regadenoson-stress myocardial CT perfusion and single-photon emission CT: rationale, design, and acquisition methods of a prospective, multicenter, multivendor comparison.

Cury RC, Kitt TM, Feaheny K, Akin J, George RT.

J Cardiovasc Comput Tomogr. 2014 Jan-Feb;8(1):2-12. doi: 10.1016/j.jcct.2013.09.004.

PMID:
24314823
11.

ST Segment Elevation ECG Changes During Pharmacologic Stress With Regadenoson.

Qamruddin S, Huang HW, Mehra A, Bonyadlou S, Yoon AJ.

Clin Nucl Med. 2016 Jan;41(1):62-4. doi: 10.1097/RLU.0000000000000990.

PMID:
26447370
12.
13.

Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole.

Friedman M, Spalding J, Kothari S, Wu Y, Gatt E, Boulanger L.

J Med Econ. 2013;16(4):449-60. doi: 10.3111/13696998.2013.772057.

PMID:
23363331
14.

The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging.

Thomas GS, Thompson RC, Miyamoto MI, Ip TK, Rice DL, Milikien D, Lieu HD, Mathur VS.

J Nucl Cardiol. 2009 Jan-Feb;16(1):63-72. doi: 10.1007/s12350-008-9001-9.

PMID:
19152130
15.

Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease.

Iskandrian AS, Verani MS, Heo J.

J Nucl Cardiol. 1994 Jan-Feb;1(1):94-111. Review.

PMID:
9420675
16.

Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy.

Bravo PE, Pozios I, Pinheiro A, Merrill J, Tsui BM, Wahl RL, Bengel FM, Abraham MR, Abraham TP.

Am J Cardiol. 2012 Oct 1;110(7):1033-9. doi: 10.1016/j.amjcard.2012.05.038.

17.

Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis.

Kim C, Kwok YS, Heagerty P, Redberg R.

Am Heart J. 2001 Dec;142(6):934-44.

PMID:
11717594
18.

Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge.

Golzar Y, Doukky R.

Int J Chron Obstruct Pulmon Dis. 2014 Jan 22;9:129-37. doi: 10.2147/COPD.S56879. Review.

19.

Effect of caffeine on myocardial perfusion imaging using single photon emission computed tomography during adenosine pharmacologic stress.

Kovacs D, Pivonka R, Khosla PG, Khosla S.

Am J Ther. 2008 Sep-Oct;15(5):431-4. doi: 10.1097/MJT.0b013e31815aec1b. Review.

PMID:
18806518
20.

Pharmacologic stress echocardiography. Dobutamine and arbutamine stress testing.

Orsinelli DA, Daniels CJ.

Cardiol Clin. 1999 Aug;17(3):461-79, viii. Review.

PMID:
10453293

Supplemental Content

Support Center